Chief Scientific Officer
CurrentNanopharm Ltd is a specialist research organization focusing on the development of inhaled medicines. We utilize bespoke analytical technologies and formulation solutions to progress the development of orally inhaled and nasal drug products. Nanopharm was acquired by AptarGroup June 2019 and the combination of Nanopharm with Aptar provides a unique opportunity for our customers to access end to end solutions for the development of orally inhaled and nasal drug products.